儿童呼吸衰竭后功能衰退与生活质量受损的危险因素
本研究基于RESTORE试验(儿童急性呼吸衰竭机械通气镇静滴定随机评估),纳入2周至17岁患儿,评估基线、出院时及儿科ICU出院后6个月的功能状态和出院后6个月的健康相关生活质量(HRQL)。949例中192例(约五分之一)从基线至出院后功能衰退;271例中55例(20%)生长与发育受损;343例中64例(19%)HRQL受损。多变量分析显示功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14,95%CI 1.22-3.76);生长与发育受损的独立预测因素包括美沙酮(OR=2.27,95%CI 1.18-4.36)和疼痛管理不足(OR=2.94,95%CI 1.39-6.19);HRQL受损与年龄较大、非白人/西班牙裔、癌症及镇静管理不足相关(OR=3.15,95%CI 1.74-5.72)。结论认为儿童呼吸衰竭后出院后发病率常见,与入院因素、重症治疗暴露及疼痛和镇静管理相关。
要点
- 949例机械通气急性呼吸衰竭患儿中192例(约五分之一)从基线至出院后功能衰退。
- 271例中55例(20%)生长与发育受损;343例中64例(19%)健康相关生活质量(HRQL)受损。
- 功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14,95%CI 1.22-3.76)。
- 生长与发育受损的独立预测因素包括美沙酮(OR=2.27,95%CI 1.18-4.36)和疼痛管理不足(OR=2.94,95%CI 1.39-6.19)。
- HRQL受损与年龄较大、非白人/西班牙裔、癌症及镇静管理不足相关(OR=3.15,95%CI 1.74-5.72)。
适用人群与场景
- 2周至17岁因急性呼吸衰竭接受机械通气的患儿,来自RESTORE试验。
- 评估时间点为基线、出院时、儿科ICU出院后6个月功能状态,以及出院后6个月HRQL。
诊断标准与关键阈值
- 基线功能正常者,若婴儿与幼儿生活质量问卷-97生长与发育评分或儿科生活质量量表总分低于常模均值超过1个标准差,则判定为HRQL受损。
研究设计与关键结果
- 研究类型为基于RESTORE试验的分析,样本量949例,人群为2周至17岁机械通气急性呼吸衰竭患儿。
- 949例中192例从基线至出院后功能衰退;271例中55例(20%)生长与发育受损;343例中64例(19%)HRQL受损。
- 多变量分析中功能衰退与基线功能受损、早产、癌症、呼吸衰竭病因、通气时长及可乐定相关(OR=2.14,95%CI 1.22-3.76)。
- 生长与发育受损的独立预测因素包括美沙酮(OR=2.27,95%CI 1.18-4.36)和疼痛管理不足(OR=2.94,95%CI 1.39-6.19)。
- HRQL受损与年龄较大、非白人/西班牙裔、癌症及镇静管理不足相关(OR=3.15,95%CI 1.74-5.72)。
证据类型、等级与局限
- 证据类型为基于RESTORE随机对照试验的队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为儿童呼吸衰竭后出院后发病率常见,与入院因素、重症治疗暴露及疼痛和镇静管理相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Poor outcomes of adults surviving critical illness are well documented, but data in children are limited.Objectives: To identify factors associated with worse postdischarge function and health-related quality of life (HRQL) after pediatric acute respiratory failure.Methods: We assessed functional status at baseline, discharge, and 6 months after pediatric ICU discharge and HRQL 6 months after discharge in 2-week- to 17-year-olds mechanically ventilated for acute respiratory failure in the RESTORE (Randomized Evaluation of Sedation Titration for Respiratory Failure) trial. We assessed HRQL via Infant and Toddler Quality of Life Questionnaire-97 (<2 yr old) or Pediatric Quality of Life Inventory (≥2 yr old). We categorized patients with normal baseline function as having impaired HRQL if scores were greater than 1 SD below mean norms for Infant and Toddler Quality of Life Questionnaire-97 growth and development or Pediatric Quality of Life Inventory total score.Measurements and Main Results: One-fifth (n = 192) of 949 patients declined in function from baseline to postdischarge; 20% (55/271) had impaired growth and development; 19% (64/343) had impaired HRQL. In multivariable analyses, decline in function was associated with baseline impaired function, prematurity, cancer, respiratory failure etiology, ventilation duration, and clonidine (odds ratio [OR] = 2.14; 95% confidence interval [CI] = 1.22-3.76). Independent predictors of impaired growth and development included methadone (OR = 2.27; 95% CI = 1.18-4.36) and inadequate pain management (OR = 2.94; 95% CI = 1.39-6.19). Impaired HRQL was associated with older age, non-white or Hispanic race, cancer, and inadequate sedation management (OR = 3.15; 95% CI = 1.74-5.72).Conclusions: Postdischarge morbidity after respiratory failure is common and associated with admission factors, exposure to critical care therapies, and pain and sedation management.
参考来源
- Watson RS, Asaro LA, Hutchins L, et al. Risk Factors for Functional Decline and Impaired Quality of Life after Pediatric Respiratory Failure. Am J Respir Crit Care Med. 2019. PMID: 31034245. doi:10.1164/rccm.201810-1881OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。